A therosclerosis is a chronic inflammatory disease of the large and medium-sized arteries, and macrophages play a central role in its initiation and progression. 1, 2 The accumulation of macrophages in lesions is attributable in part to recruitment of monocytes from the bloodstream, 2 and also to proliferation of macrophages within atherosclerotic lesions. [3] [4] [5] [6] Hence, comprehensive understandings of how macrophage populations in the artery are regulated require knowledge of factors that control the survival and proliferation of macrophages in the arterial intima.
Oxidized low-density lipoprotein (oxLDL) plays an important role in atherogenesis, in part because of its effects on macrophage recruitment and retention. 7, 8 Initial oxidation of LDL and formation of what is often referred to as "minimally modified" LDL stimulates adjacent endothelial and smooth muscle cells to release monocyte chemotactic protein-1 (MCP-1), which facilitates the recruitment of monocytes into the arterial wall. OxLDL itself is chemotactic for monocytes by virtue of its lysophosphatidylcholine content.
At high concentrations, oxLDL can be toxic to cultured macrophages and other cells, but at lower concentrations it has clearly been shown to promote macrophage proliferation and inhibit apoptosis. 9 -15 It has been reported that an increase in intracellular calcium ([Ca 2ϩ ] i ) is required for oxLDL to promote macrophage proliferation. 16 However, the downstream mechanisms that are activated by the increased [Ca 2ϩ ] i , have not been fully explored. Eukaryotic elongation factor-2 kinase (eEF2 kinase), also known as calcium/calmodulin dependent kinase III, is a highly conserved protein kinase first identified by Nairn et al. 17 It has been shown to regulate many cellular processes through its role in protein translation. 18 eEF2 kinase controls the movement of the elongating peptide chain by specifically phosphorylating eEF2 at Thr56, which decreases the affinity of the elongation factor for the ribosome. 18 -20 The activity of eEF2 kinase has been found to be upregulated in many human cancers, 21, 22 and inhibition by selective inhibitors produced cancer cell death in vitro and in vivo. 23, 24 Several lines of evidence suggest that eEF2 kinase may be involved in cell survival during times of nutrient deprivation. First, eEF2 kinase regulates protein synthesis, a major consumer of cellular energy. Second, growth factor withdrawal can markedly reduce the activity of eEF2 kinase. Wu et al reported that eEF2 kinase promotes cell survival in glioblastomas when nutrients are withdrawn, 25 and Terai et al reported that eEF2 kinase can protect cardiomyocytes during hypoxic injury. 26 In this study, we report that oxLDL can activate eEF2 kinase in bone marrow-derived macrophages (BMDM), resulting in the inhibition of protein synthesis and inhibition of apoptosis during growth factor deprivation.
Materials and Methods
An expanded Materials and Methods section can be found in the supplemental materials (available online at http://atvb.ahajournals. org). In brief, density ultracentrifugation isolation of LDL and its oxidation by copper sulfate was carried out as previously described. 15 Bone marrow-derived macrophages were isolated from the femurs of 6-to 8-week-old female CD-1 mice. 15 Calcium mobilization was assessed by confocal fluorescence microscopy. Human eEF2 was purified from HL-60 cell homogenates with antihuman eEF2. Activity of eEF2 kinase was quantified by monitoring the formation of phospho-eEF2 with an anti-human phospho-eEF2 antibody. Cell viability was assessed by measuring the rate of reduction of a formazan dye. 15 
Results

OxLDL Induces an Increase in [Ca 2؉ ] i
OxLDL has been previously shown to mobilize calcium in peritoneal macrophages and macrophage-like cell lines. 27, 28 Using Fluo-4-AM and fluorescence confocal microscopy, we were able to visualize calcium fluxes in real-time in response to oxLDL treatment. Figure 1D ). Because fluorescence intensity of each cell was independently measured over time, we were able to make the novel observation that the increase in [Ca 2ϩ ] i induced by oxLDL, but not nLDL, actually involves calcium oscillations ( Figure 1A ). In contrast, this specific effect was almost completely absent in nLDL-treated cells. Additionally, the magnitude of the [Ca 2ϩ ] i increase was, on average, lower in cells treated with nLDL in comparison with cells treated with oxLDL ( Figure 1B ). As expected, preincubation with the cell permeable calcium chelator, BAPTA-AM, completely ablated calcium mobilization ( Figure 1C and 1D) . 
eEF2 Kinase Is Activated in Response to oxLDL
eEF2 is the only known substrate for eEF2 kinase, which it phosphorylates at Thr56. 19 eEF2 kinase activity was assessed by incubating BMDM lysates with eEF2 and measuring levels of phosphorylated eEF2 by immunoblotting. An increase in eEF2 kinase activity was detectable as early as 15 minutes after the addition of oxLDL and was maximal by 30 minutes (Figure 2a) . eEF2 kinase is a calcium/calmodulin-dependent kinase that can be activated when [Ca 2ϩ ] i levels increase. 18, 29, 30 Our results demonstrate that oxLDL mobilizes calcium into the intracellular space almost immediately after its addition, an effect that can be blocked by 20 mol/L BAPTA-AM ( Figure  1C and 1D) . At the same concentration, BAPTA-AM also blocks oxLDL-mediated eEF2 phosphorylation ( Figure 2B ). This suggests that eEF2 kinase is activated in response to oxLDL via an increase in [Ca 2ϩ ] i . Previous reports have suggested that oxLDL-mediated macrophage proliferation is dependent on a calcium mediated activation of protein kinase C (PKC). 10, 16, 31 Of the PKC isoforms that are activated in response to Ca 2ϩ (␣, ␤, ␥), only PKC␣ and PKC␤ are expressed in macrophages. 32 Depletion of PKC by incubation (for 72 hours) with phorbol myristate acetate (PMA) or incubation with the PKC␣/␤ selective inhibitor Ro 32-0432 did not alter the viability of macrophages, or their survival response to oxLDL treatment (supplemental Figure I ).
eEF2 Kinase Activity Is Required for oxLDL-Mediated Macrophage Survival
The eEF2 kinase selective inhibitors TS-4 33 and TX-1918 34 effectively blocked the phosphorylation of eEF2 by oxLDL ( Figure 2B ). At corresponding concentrations, both TS-4 and TX-1918 lowered the viability of cells treated with oxLDL to levels similar to that of cytokine starved cells ( Figure 3A and 3B). These inhibitors had no effect on the viability of macrophages not treated with oxLDL, indicating that they act specifically on the antiapoptotic effect of oxLDL and do not simply decrease macrophage viability. Moreover, both TS-4 and TX-1918 induced cellular apoptosis in oxLDL-treated BMDM to levels similar to that of cytokine-starved cells ( Figure 3F ).
During purification, eEF2 kinase has been found to be tightly associated with Hsp90, and disruption of the eEF2 kinase/Hsp90 complex by geldanamycin inhibited the clonogenicity of glioblastoma cell lines. 35, 36 Figure 2B shows that geldanamycin blocked the ability of oxLDL to induce eEF2 phosphorylation, and it was also able to block oxLDLmediated effects on macrophage viability and inhibition of apoptosis ( Figure 3C and 3F).
In addition to copper-oxidized LDL, recent reports have suggested the biological relevance of myeloperoxidaseoxidized LDL (MPO-LDL) in promoting atherosclerosis. 37 To determine whether the prosurvival effect of MPO-LDL is similar to that of copper-oxidized oxLDL, macrophage viability was measured in response to treatment with MPO-LDL. As seen in supplemental Figure II , 50 g/mL MPO-LDL was as effective as 25 g/mL copper oxLDL in promoting macrophage survival, and the addition of the eEF2 kinase selective inhibitor, TX-1918, blocked this effect.
Recently, an eEF2 kinase-dead transgenic mouse line was developed. Our preliminary experiments with these mice shows that eEF2 kinase activity plays a positive role in oxLDL-mediated macrophage survival (supplemental Figure  III) . Future studies will further evaluate the effect of the lack of eEF2 kinase activity on oxLDL-dependent macrophage survival in vivo as well as the effect on atherosclerosis progression in a mouse model.
Taken together, these results indicate that the ability of oxLDL to block macrophage apoptosis is dependent on its ability to activate eEF2 kinase.
p38 MAPK Negatively Regulates eEF2 Kinase Activity and Is Phosphorylated upon Growth Factor Withdrawal
Knebel et al reported that p38␦ MAPK phosphorylates eEF2 kinase at Ser359 and Ser396, and inhibits its activity by A B Figure 2 . eEF2 kinase activation and regulation. Activity of eEF2 kinase was measured in BMDM lysates after the incubations described below using immunoblot analysis for phosphorylated eEF2. A, BMDM were incubated in medium without M-CSF for 4 hours, and 25 g/mL oxLDL was then added for the times indicated. B, BMDM were incubated in media without M-CSF for 4 hours. Then, the p38 MAPK inhibitor SB202190 (15 mol/L), the p38 MAPK activator anisomycin (250 nmol/L), the extracellular calcium chelator BAPTA-AM (20 mol/L), C 2 ceramide (25 mol/L), the Hsp90 inhibitor geldanamycin (12 nmol/L), or the eEF2 kinase inhibitors TS-4 (3.5 mol/L) or TX-1918 (8 mol/L) were added to cells for 10 minutes. OxLDL (25 g/mL) was then added for a further 30 minutes.
approximately 80%. 38 Other p38 MAPK isoforms are of lesser importance beacuse p38␣, which phosphorylates eEF2 kinase at Ser377, did not affect its activity and p38␤, which phosphorylates eEF2 kinase at Ser396, 39 caused only a modest decrease in activity. To assess the role of p38 MAPK isoforms in the antiapoptotic effect of oxLDL, we incubated BMDM with anisomycin, a pyrrolidine antibiotic that activates p38 MAPK. 38 At 250 nmol/L, anisomycin blocked activation of eEF2 kinase by oxLDL ( Figure 2B ). At the same concentration, anisomycin also decreased macrophage viability ( Figure 3D ) and induced apoptosis ( Figure 3F ). SB202190, a selective inhibitor of p38␣ and p38␤ but not p38␦, 40 was not able to rescue macrophages from apoptosis because of macrophage colony stimulating factor (M-CSF) withdrawal ( Figure 3E ), in agreement with the limited role of p38␣ and p38␤ in regulating eEF2 kinase activity as discussed above. p38 MAPK phosphorylation was observed as early as 15 minutes after M-CSF withdrawal ( Figure 4A ). Of interest, p38 MAPK phosphorylation was inhibited by the addition of oxLDL ( Figure 4B ). Thus, oxLDL can not only activate eEF2 kinase by mobilizing [Ca 2ϩ ] i , but can also inhibit its negative regulation by blocking p38 MAPK activation. Conversely, as would be predicted based on the ability of anisomycin to activate p38 MAPK, the addition of anisomycin negated the inhibition of p38 MAPK phosphorylation by oxLDL ( Figure 4B ).
Ceramide Activates p38 MAPK and Negatively Regulates eEF2 Kinase Activity
Our group has previously shown that incubation of BMDM in the absence of M-CSF results in activation of acid sphingomyelinase (ASMase) and an increase in ceramide levels. 15 OxLDL blocked both of these effects, whereas the addition of C 2 -ceramide blocked the ability of oxLDL to induce survival. In the present study, we found that C 2 -ceramide can also block activation of eEF2 kinase by oxLDL ( Figure 2B ). As well, C 2 -ceramide induced phosphorylation of p38 MAPK ( Figure 4C ), in agreement with previous reports in other macrophage cell types. 41, 42 At present, we cannot be certain whether the effect of ceramide on eEF2 kinase is mediated entirely by its activation of p38 MAPK or whether there is another mechanism as well.
Protein Synthesis Is Reduced in Response to oxLDL
eEF2 is a monomeric GTPase that facilitates translocation of peptidyl t-RNA from the ribosomal A site to P site. 20 Phosphorylation of eEF2 by eEF2 kinase leads to an inhibition of eEF2 and therefore of protein synthesis. 18 To determine whether the oxLDL-mediated phosphorylation of eEF2 has the expected effect on protein synthesis, the in vivo incorporation rates of L- 5). This correlated well to the timing of eEF2 phosphorylation in response to oxLDL (Figure 2A ), suggesting that oxLDL mediates a reduction in protein synthesis via the activation of eEF2 kinase.
Discussion
Calcium is a universal second messenger that regulates a number of diverse cellular processes including cell proliferation, development, motility, and secretion. 43 In all eukaryotic cells, Ca 2ϩ is required in both the extracellular environment and intracellular stores for cell growth and division. Recent studies have proposed that Ca 2ϩ may be an important factor in the early development and progression of atherosclerotic lesions. 44, 45 The use of calcium antagonists in clinical studies have been reported to retard the progression of the disease. 46 Furthermore, alterations in Ca 2ϩ gradients by oxLDL have been implicated in the formation of macrophage-derived foam cells. 47 Ca 2ϩ can relay specificity in signaling through its temporal diversity. 43 In response to some types of stimuli, there may be repetitive Ca 2ϩ spikes (Ca 2ϩ oscillations). Whereas a transient or sustained increase in [Ca 2ϩ ] i is generally associated with apoptosis, calcium oscillations favor cell survival by enhancing mitochondrial bioenergetics. 48 Cells respond to calcium oscillations using highly sophisticated mechanisms, including the ability to interpret changes in its frequency. One family of molecular machines that can interpret such frequency changes is the calcium/calmodulin-dependent kinases. 49 eEF2 kinase, or calcium/calmodulin-dependent kinase III, is a highly regulated enzyme. To date, there are 7 known phosphorylation sites. 38,39,50 -53 Phosphorylation at 6 of these sites through the p38 MAPK, mTor, Erk, AMPK or PKA pathways regulate its activity either positively or negatively. Specific agonists and inhibitors targeting mTOR, Erk, and PKA all failed to alter macrophage viability in response to oxLDL (data not shown).
In this article, we identified a novel mechanism by which oxLDL prevents macrophage apoptosis in response to growth factor withdrawal. OxLDL initiates an almost immediate oscillatory increase in [Ca 2ϩ ] i . This is followed by the activation of the Ca 2ϩ sensitive eEF2 kinase. Specific inhibition of eEF2 kinase activity completely blocks the antiapoptotic effects of oxLDL. Whereas a previous study suggested a role of PKC in calcium-induced proliferation of peritoneal macrophages in response to oxLDL, 16 our results suggest that PKC is not required for the antiapoptotic effect of oxLDL in BMDM.
Upon growth factor withdrawal p38 MAPK phosphorylation was detected, an effect that can be blocked by the addition of oxLDL. Phosphorylation of eEF2 kinase by p38 MAPK negatively regulates its activity. 38 Activation of p38 MAPK by anisomycin was shown to block oxLDL activation of eEF2 kinase and induce apoptosis. Taken together, these observations suggest that oxLDL positively regulates eEF2 kinase not only by increasing [Ca 2ϩ ] i , but through inhibiting its negative regulation by blocking p38 MAPK activation. A summary of the signaling pathways involved in oxLDLmediated macrophage survival can be found in the supplemental Figure IV .
Activation of eEF2 kinase results in the phosphorylation and inhibition of its only known substrate, eEF2. eEF2 is a monomeric GTPase and serves as an elongation factor that facilitates translocation of peptidyl t-RNA from the ribosomal A site to P site. 20 The addition of oxLDL resulted in the reduction of protein synthesis in a time frame that correlates well with our observation of eEF2 phosphorylation by oxLDL.
Recent studies have implicated the important role of eEF2 kinase in protecting cells during times of stress, such as hypoxia or nutrient deprivation. A possible mechanism is that eEF2 phosphorylation can inhibit the synthesis of proteins that promote apoptosis, as has been suggested in studies involving postischemic neuronal cells. 54 Additionally, Terai et al have shown that the activation of eEF2 kinase protects cardiomyocytes against ER stress-induced apoptosis during hypoxia, via inhibition of ER stress-induced production of misfolded proteins. 26 Wu et al, however, link the protective role of eEF2 kinase with the conservation and replenishment of cellular energy during nutrient deprivation, through an eEF2 kinase-dependent activation of autophagy. 25 The precise nature of how the activation of eEF2 kinase leads to macrophage survival is still unclear. One hypothesis is that the activation of eEF2 kinase, via oxLDL-mediated increase in [Ca 2ϩ ] i during times of nutrient deprivation or withdrawal of M-CSF, switches the cells from an apoptotic to an autophagic cell survival state. Our study has shown that oxLDL-mediated cell survival requires eEF2 kinase activation, which leads to phosphorylation and inhibition of eEF2 and a reduction in protein synthesis. This suggests that oxLDL may promote cell survival during times of nutrient deprivation by lowering cellular energy consumption via a reduction in protein translation. 
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Materials
Lipoprotein Isolation and Oxidation
Procedures for LDL isolation and copper oxidation are as previously reported by our times that of native LDL, but showed no pro-survival activity (data not shown).
Cell Culture
Bone marrow cells were obtained from the femurs of 6-8 week old female CD-1 mice, or from eEF2 kinase inactive transgenic mice (and litter mate controls), and macrophages were isolated from these as previously described 2 .
Flow Cytometry
BMDM were seeded in 6-well plates at 5.0 x 10 4 cells per cm 2 and grown for 24 hours.
Cells were then washed and incubated with media containing oxLDL to a concentration of 25 µg/ml and/or other compounds for 24 hours. Cells were harvested using a rubber cell scraper and 
Immunoblotting
Cells were washed with DPBS and lysed with ice-cold solubilization buffer. Lysates were centrifuged at 20,000 x g for 10 minutes, and the protein content of supernatants was quantified using BCA protein assay. Sample buffer was added to the lysates and heated to 70°C for 10 minutes. 50 µg of protein from each sample was loaded onto a SDS-PAGE gel. Gels were calibrated using pre-stained SDS-PAGE low molecular weight standards. Proteins were then transferred electrophoretically to PVDF membranes and then incubated with 1 µg/ml primary antibody in Tris-buffered saline (TBS) containing 3 mmol/L sodium azide, and either 1% skim milk or 1.5 mmol/L BSA at room temperature for 2 hours. After three washes with TBS containing 0.1% Tween 20 (TBS-T), membranes were incubated with horseradish peroxidaseconjugated secondary antibody at 1:10,000 dilution in TBS containing 3 mmol/L sodium azide, 
